← FDA DRUG APPROVALS

FDA ANDA · ANDA203918

SODIUM PHENYLBUTYRATE

Sponsor: PH HEALTH

APPLICATION
ANDA203918
TYPE
ANDA
ORIGINAL APPROVAL
2016-06-15
LATEST ACTION
2016-06-15
ROUTE
ORAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription

Products

SODIUM PHENYLBUTYRATEPrescription
SODIUM PHENYLBUTYRATE 3GM/TEASPOONFUL · POWDER · ORAL

Approval history

2016-06-15UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →